Janus kinase inhibitors and uses thereof
Abstract:
The invention described herein pertains to selective Janus kinase (JAK) inhibitors and methods of use thereof. Also described are methods for treating diseases involved abnormal JAK/STAT signaling pathway in mammals using the described selective JAK inhibitors or a pharmaceutical formulation thereof.
Public/Granted literature
Information query
Patent Agency Ranking
0/0